As the potential impact of generative AI (GenAI) on health in low- and middle-income countries (LMICs) continues to be explored, two key questions emerge: Where is GenAI currently being used most effectively, and how can its full potential be unlocked for greater impact, both for behavior change and broader healthcare applications? A newly released white paper sheds light on these questions, offering insights from a comprehensive review led by the Stanford Center for Digital Health (CDH) with support from Advancing Health Online (AHO) and the Bay Area Global Health Alliance as lead dissemination partner.
